Summary of Purpose
Background: stroke is a major cause of death and disability. Intravenous thrombolysis and mechanical thrombectomy are able to re-open occluded vessels and save the ischemic tissue from death. However, recanalization of the occluded vessel may trigger activation of detrimental molecular pathways and exacerbate blood brain barrier (BBB) disruption, eventually determining hemorrhagic transformation (HT) or cerebral...Read More →
The following dates are available for this trial. Trial information last updated on 2 February 2017.
|1 Sep 2015||23 Aug 2016||1 Aug 2018||1 Nov 2018||1 Feb 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Domenico Inzitari, MD
- Benedetta Piccardi, MD